|
|
|
|
|
Company News |
|
|
|
HD Biosciences and MDS Pharma Services Partnering Together for Future |
|
HD Biosciences, an integrated Drug Discovery and Development company based in Shanghai, China announced today that it has entered into a partnership with MDS Pharma Services (King of Prussia, PA, USA), a leading provider of innovative drug discovery and early stage development solutions.
Via this partnership, HD Biosciences (HDB) will initially provide support to MDS Pharma Services¡¯ Pharmacology/DMPK division in compound management to serve their mutual customers. HDB will also provide resources and facilities in assay development and compound screening for MDS Pharma Services in specific service areas at HDB¡¯s Shanghai operation site. The agreement also enables HDB to gain additional scientific training and support from MDS Pharma Services in specific technical service areas. |
|
"HD Biosciences is delighted to partner with MDS Pharma Services to mutually facilitate one another's comprehensive preclinical drug discovery research services in multiple geographic regions. HDB's Shanghai operation site can assist not only in compound management but also serve as a Chinese operation extension for MDS Pharma Services when there is a need. The joint effort will boost the global competitiveness for both companies in the drug discovery and development outsourcing market." Commented by Angela Chen, PhD, MBA, Head of Business Development for HD Biosciences. |
|
"MDS Pharma Services is enthusiastic about this partnership with HD Biosciences. Access to the expedited compound management process ensures on-time delivery of our high quality molecular pharmacology and DMPK services to support drug discovery projects in China and enhances our global reach to meet the outsourcing needs of our clients.¡± said Susan Wang, PhD, Strategic Director ¨C Asia for MDS Pharma Services. ¡°We intend to further collaborate with HD Biosciences in various technical areas to expand our capabilities and to maximize the potential of the emerging market as an international leader among biology CROs." |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
---------------------- |
|
|
|
---------------------- |
|
|
|
|
|
|
|
|
|
|
